TAES for FPVCs: a Pragmatic, Randomized Controlled Trial
RecruitingNCT04415203Phase: NAStarted 2020-06-04
Summary
This prospective, randomized controlled trial aims to evaluate the efficacy and safety of Transcutaneous Auricular Vagus Nerve Stimulation (TAVNS) for patients with frequent premature ventricular coom
Eligibility
Sex
ALL
Min Age
18 Years
Max Age
75 Years
Locations
Guang'anmen Hospita, China Academy of Chinese Medical SciencBeijing, Beijing Municipality, China
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT04415203